UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Higher Brain Blood Flow at Amygdala and Lower Frontal Cortex Blood Flow in PTSD Patients with Comorbid Cocaine and Alcohol Abuse Compared with Normals

Psychiatry (Washington, D.C.), 2000-04, Vol.63 (1), p.65-74

2000

Volltextzugriff (PDF)

In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)

Clinical and experimental immunology, 1988, Vol.74 (3), p.392-397

1988

Volltextzugriff (PDF)

Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro

Transplantation, 1986-06, Vol.41 (6), p.716

1986

Volltextzugriff (PDF)

Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial

Oncology, 1985, Vol.42 Suppl 1, p.7

1985

Volltextzugriff (PDF)

Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients

Leukemia, 1989-06, Vol.3 (6), p.453-460

1989

Volltextzugriff (PDF)

Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma

Oncology, 1985, Vol.42 Suppl 1, p.26

1985

Volltextzugriff (PDF)

Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing

Blut, 1986-05, Vol.52 (5), p.273-279

1986

Volltextzugriff (PDF)

RECOMBINANT α2 INTERFERON FOR INDUCTION AND MAINTENANCE OF REMISSION IN HAIRY CELL LEUKAEMIA

British journal of haematology, 1985-11, Vol.61 (3), p.581-582

1985

Volltextzugriff (PDF)

Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma

Journal of biological regulators and homeostatic agents, 1987-04, Vol.1 (2), p.81

1987

Volltextzugriff (PDF)

Interferon-alpha-2 in the treatment of idiopathic myelofibrosis

Blut, 1988-04, Vol.56 (4), p.161-163

1988

Volltextzugriff (PDF)

Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies

Molecular biotherapy, 1988, Vol.1 (1), p.21

1988

Volltextzugriff (PDF)

Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies

Oncology, 1985, Vol.42 Suppl 1, p.3

1985

Volltextzugriff (PDF)

Anxiolytics and beta blockers: evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables

Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1981-10, Vol.22 (C), p.5

1981

Volltextzugriff (PDF)

Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia

Onkologie, 1985-01, Vol.8 (3), p.143

1985

Volltextzugriff (PDF)

Enhanced serum levels of β-2-microglobulin neopterin, and interferon-γ in patients treated with recombinant tumor necrosis factor-α

Journal of interferon research, 1988-10, Vol.8 (5), p.655-664

1988

Volltextzugriff (PDF)

Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations

Current therapeutic research, 1976-12, Vol.20 (6), p.810-821

1976

Volltextzugriff (PDF)

Die intraperitoneale Instillation von Interferon-gamma zur Behandlung des refraktären Ovarialkarzinoms

Geburtshilfe und Frauenheilkunde, 1989-11, Vol.49 (11), p.987-991

1989

Volltextzugriff (PDF)

Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders

Cancer Immunology Immunotherapy, 1987-11, Vol.25 (3), p.266-273

1987

Volltextzugriff (PDF)

Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial

European journal of cancer & clinical oncology, 1986-09, Vol.22 (9), p.1111-1116

1986

Volltextzugriff (PDF)

Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression

Cancer research (Chicago, Ill.), 1985-07, Vol.45 (7), p.2957-2961

1985

Volltextzugriff (PDF)

Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial

European journal of cancer & clinical oncology, 1991, Vol.27 (4), p.462-467

1991

Volltextzugriff (PDF)

Interferon-γ for the Treatment of Metastatic Renal Cancer: Dose-Dependent Stimulation and Downregulation of Beta-2 Microglobulin and Neopterin Responses

The Journal of urology, 1989-02, Vol.141 (2), p.472-472

1989

Volltextzugriff (PDF)

A Biological Approach to Optimize Interferon Treatment in Hairy Cell Leukemia

Immunobiology (1979), 1986-09, Vol.172 (3), p.262-268

1986

Volltextzugriff (PDF)

Interferon-γ for the treatment of metastatic renal cancer: Dose-dependent stimulation and downregulation of beta2 microglobulin and neopterin responses

Immunobiology (1979), 1987, Vol.176 (1), p.85-95

1987

Volltextzugriff (PDF)

Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid

Wiener Klinische Wochenschrift, 1988-11, Vol.100 (21), p.715-718

1988

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(34)
Science & Technology
(24)
Male
(22)
Adult
(20)
Female
(19)
Life Sciences & Biomedicine
(18)
Middle Aged
(18)
Interferon Type I - Therapeutic Use
(17)
Aged
(16)
Recombinant Proteins - Therapeutic Use
(16)
Biological And Medical Sciences
(12)
Drug Evaluation
(12)
Medical Sciences
(10)
Dose-Response Relationship, Drug
(9)
Interferon Type I - Adverse Effects
(9)
Oncology
(8)
Biopterins - Analogs & Derivatives
(7)
Neopterin
(7)
Recombinant Proteins - Adverse Effects
(7)
Clinical Trials As Topic
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Higher Brain Blood Flow at Amygdala and Lower Frontal Cortex Blood Flow in PTSD Patients with Comorbid Cocaine and Alcohol Abuse Compared with Normals

In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)

Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro

Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial

Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients

Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma

Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing

RECOMBINANT α2 INTERFERON FOR INDUCTION AND MAINTENANCE OF REMISSION IN HAIRY CELL LEUKAEMIA

Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma

Interferon-alpha-2 in the treatment of idiopathic myelofibrosis

Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies

Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies

Anxiolytics and beta blockers: evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables

Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia

Enhanced serum levels of β-2-microglobulin neopterin, and interferon-γ in patients treated with recombinant tumor necrosis factor-α

Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations

Die intraperitoneale Instillation von Interferon-gamma zur Behandlung des refraktären Ovarialkarzinoms

Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders

Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial

Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression

Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial

Interferon-γ for the Treatment of Metastatic Renal Cancer: Dose-Dependent Stimulation and Downregulation of Beta-2 Microglobulin and Neopterin Responses

A Biological Approach to Optimize Interferon Treatment in Hairy Cell Leukemia

Interferon-γ for the treatment of metastatic renal cancer: Dose-dependent stimulation and downregulation of beta2 microglobulin and neopterin responses

Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid

Suchergebnisse filtern